{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:54Z","timestamp":1786984374038,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.annepidem.2025.04.017","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T11:54:56Z","timestamp":1746273296000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Estimating the population need for preexposure prophylaxis for HIV in the United States"],"prefix":"10.1016","volume":"106","author":[{"given":"Athena P.","family":"Kourtis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minttu M.","family":"R\u00f6nn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Lin A.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Lyles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupa R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen W.","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn Neblett","family":"Fanfair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Mermin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2025.04.017_bib1","unstructured":"Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142021 Update: a clinical practice guideline. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2021.pdf. 2021.."},{"issue":"12","key":"10.1016\/j.annepidem.2025.04.017_bib2","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/cid\/ciz1229","article-title":"Evidence of an association of increases in pre-exposure prophylaxis coverage with decrease in HIV diagnosis rates in the United States, 2012-2016","volume":"71","author":"Smith","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"March","key":"10.1016\/j.annepidem.2025.04.017_bib3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV Epidemic. A plan for the United States","volume":"21","author":"Fauci","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2025.04.017_bib4","unstructured":"EHE Indicators: PrEP Coverage. Available at: https:\/\/www.hiv.gov\/blog\/ahead-dashboard-ehe-indicators-prep-coverage. Accessed May 25, 2021."},{"key":"10.1016\/j.annepidem.2025.04.017_bib5","first-page":"1","article-title":"Estimates of adults with indications for HIV PrEP by jurisdiction, transmission risk group, and race\/ethnicity, United States 2015","author":"Smith","year":"2018","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annepidem.2025.04.017_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/QAI.0000000000002300","article-title":"Estimated number of MSM with indications for HIV PrEP in a National Sexual Network Study","volume":"84","author":"Weiss","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.annepidem.2025.04.017_bib7","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3390\/ijerph15081696","article-title":"Bias adjustment techniques are underutilized in HIV sexual risk estimation: a systematic review","volume":"15","author":"Tran","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"10.1016\/j.annepidem.2025.04.017_bib8","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/QAI.0000000000002791","article-title":"Updated estimates of the number of men who have sex with men (MSM) with indications for HIV pre-exposure prophylaxis","volume":"88","author":"Bates","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.annepidem.2025.04.017_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAI.0000000000002042","article-title":"Current US guidelines for prescribing HIV pre-exposure prophylaxis (PrEP) disqualify many women who are at risk and motivated to use PrEP","volume":"81","author":"Calabrese","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.annepidem.2025.04.017_bib10","first-page":"841","article-title":"The prevalence of PrEP use and the PrEP-to-need ratio in the fourth quarter of 2017, United States. Annals","volume":"28","author":"Siegler","year":"2018","journal-title":"Epidemiol"},{"key":"10.1016\/j.annepidem.2025.04.017_bib11","unstructured":"Aids Vu. Understanding HIV where you live. Available at: https:\/\/aidsvu.org\/local-data\/united-states\/south\/georgia\/#prep. Accessed May 25, 2021."},{"issue":"6","key":"10.1016\/j.annepidem.2025.04.017_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1473-3099(14)70025-8","article-title":"HIV prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial","volume":"14","author":"Buchbinder","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.annepidem.2025.04.017_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/cid\/ciad537","article-title":"Global HIV Incidence analysis and implications for affordability using long-acting cabotegravir versus continuous and event-driven oral Preexposure prophylaxis","volume":"78","author":"Sharma","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.annepidem.2025.04.017_bib14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV prevention in cigender men and transgender women","volume":"385","author":"Landovitz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2025.04.017_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26109","article-title":"Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings: a model comparison analysis","volume":"26","author":"Stansfield","year":"2023","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"10.1016\/j.annepidem.2025.04.017_bib16","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3390\/ijerph16091592","article-title":"Estimated impact of targeted pre-exposure prophylaxis: strategies for men who have sex with men in the United States","volume":"16","author":"Elion","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.annepidem.2025.04.017_bib17","unstructured":"Tao L., Yang J., Hojilla J.C., Chokkalingam A., Carter C., Das M. PrEP non persistence and new HIV Diagnoses: A real-world analysis of >\u2009120,000 people prescribed PrEP. 31st CROI 2024, Poster 1124, March 3-6 2024, Denver, Colorado, USA."},{"issue":"12","key":"10.1016\/j.annepidem.2025.04.017_bib18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.annepidem.2018.04.008","article-title":"Rates of prevalent and new HIV diagnoses by race and ethnicity among men who have sex with men, U.S. states, 2013-2014","volume":"28","author":"Rosenberg","year":"2018","journal-title":"Ann Epidemiol"},{"issue":"4","key":"10.1016\/j.annepidem.2025.04.017_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.7326\/M21-1548","article-title":"Cost-effectiveness of long-acting injectable HIV preexposure prophylaxis in the United States: a cost-effectiveness analysis","volume":"175","author":"Neilan","year":"2022","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.annepidem.2025.04.017_bib20","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/cid\/cit437","article-title":"incidence among men with and those without sexually transmitted rectal infections: estimates from matching against an HIV case registry","volume":"57","author":"Pathela","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.annepidem.2025.04.017_bib21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/aje\/153.7.619","article-title":"Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study","volume":"153","author":"Seage","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.annepidem.2025.04.017_bib22","article-title":"Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061","volume":"26","author":"Koblin","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.annepidem.2025.04.017_bib23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jama.2024.0464","article-title":"HIV Preexposure prophylaxis with emtricinabine and tenofovir disoproxil fumarate among cisgender women","volume":"331","author":"Marrazzo","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.annepidem.2025.04.017_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-158-1-201301010-00004","article-title":"HIV acquisition among women from selected areas of the United States: a cohort study","volume":"158","author":"Hodder","year":"2013","journal-title":"Ann Intern Med"},{"issue":"9883","key":"10.1016\/j.annepidem.2025.04.017_bib25","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2025.04.017_bib26","article-title":"Missed opportunities for prevention: prevalence and incidence of HIV and Hepatitis C virus diagnoses among a cohort of individuals discharged from an urban hospital with injection drug-related diagnoses, 2012-2019. Annals","volume":"80","author":"Evans","year":"2023","journal-title":"Epidemiol"},{"issue":"5","key":"10.1016\/j.annepidem.2025.04.017_bib27","article-title":"Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations","volume":"12","author":"Murchu","year":"2022","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.annepidem.2025.04.017_bib28","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/cid\/civ778","article-title":"No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting","volume":"61","author":"Volk","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10013","key":"10.1016\/j.annepidem.2025.04.017_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.annepidem.2025.04.017_bib30","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/cid\/cix593","article-title":"Redefining human immunodeficiency virus (HIV) preexposure prophylaxis failures","volume":"65","author":"Marcus","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.annepidem.2025.04.017_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","article-title":"Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health Services","volume":"176","author":"Liu","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.annepidem.2025.04.017_bib32","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1016\/S2468-2667(22)00106-2","article-title":"Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study","volume":"7","author":"Jourdain","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.annepidem.2025.04.017_bib33","unstructured":"Zhu W., Huang Y.A., Kourtis A.P., Hoover K. Oral and injectable PrEP use in the United States, 2013 to 2022. CROI. Seattle WA, 2023."},{"key":"10.1016\/j.annepidem.2025.04.017_bib34","unstructured":"Centers for Disease Control and Prevention. NCHHSTP AtlasPlus. Available at: https:\/\/www.cdc.gov\/nchhstp\/atlas\/index.htm.."},{"issue":"3","key":"10.1016\/j.annepidem.2025.04.017_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1089\/apc.2019.0259","article-title":"Factors associated with HIV seroconversion among women attending an urban health clinic in the South: a matched case-control study","volume":"34","author":"Harrington","year":"2020","journal-title":"AIDS Patient Care STDS"},{"issue":"S4","key":"10.1016\/j.annepidem.2025.04.017_bib36","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2018.304762","article-title":"Patterns of racial\/ethnic disparities and prevalence in HIV and syphilis diagnoses among men who have sex with men, 2016: a novel data visualization","volume":"108","author":"Sullivan","year":"2018","journal-title":"Am J Public Health"},{"issue":"12","key":"10.1016\/j.annepidem.2025.04.017_bib37","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1007\/s10461-019-02420-z","article-title":"Characteristics of persons who inject drugs with recent HIV infection in the United States: national HIV behavioral surveillance, 2012","volume":"23","author":"Chapin-Bardales","year":"2019","journal-title":"AIDS Behav"},{"issue":"6","key":"10.1016\/j.annepidem.2025.04.017_bib38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/sextrans-2018-053808","article-title":"Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial","volume":"96","author":"White","year":"2019","journal-title":"Sex Transm Infect"},{"issue":"1","key":"10.1016\/j.annepidem.2025.04.017_bib39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1186\/s12879-023-08719-6","article-title":"Evaluation of multiple data sources for predicting increased need for HIV prevention among cisgender women: understanding missed opportunities for Pre-exposure Prophylaxis (PrEP)","volume":"23","author":"Johnson","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.annepidem.2025.04.017_bib40","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/aid.2015.0013","article-title":"The effect of high rates of bacterial sexually transmitted infections on HIV incidence in a cohort of black and white men who have sex with men in Atlanta, Georgia","volume":"31","author":"Kelley","year":"2015","journal-title":"AIDS Res Hum Retrovir"},{"issue":"2","key":"10.1016\/j.annepidem.2025.04.017_bib41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/cid\/ciac775","article-title":"Development of a human immunodeficiency virus risk prediction model using electronic health record data from an academic health system in the Southern United States","volume":"76","author":"Burns","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.annepidem.2025.04.017_bib42","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciu184","article-title":"Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men--STD Surveillance Network, United States, 2010-2012","volume":"58","author":"Patton","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.annepidem.2025.04.017_bib43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/QAI.0b013e3181c3ef29","article-title":"Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion","volume":"53","author":"Bernstein","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"10.1016\/j.annepidem.2025.04.017_bib44","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/OLQ.0000000000000614","article-title":"New human immunodeficiency virus diagnosis independently associated with rectal gonorrhea and chlamydia in men who have sex with men","volume":"44","author":"Barbee","year":"2017","journal-title":"Sex Transm Dis"}],"updated-by":[{"DOI":"10.1016\/j.annepidem.2025.09.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279725000900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279725000900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T08:28:17Z","timestamp":1747729697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279725000900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"alternative-id":["S1047279725000900"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2025.04.017","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the population need for preexposure prophylaxis for HIV in the United States","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2025.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}